8VC
VC Fund
San Francisco, United States
8VC is a technology and life sciences investment firm that partners with founders to develop transformational technologies. The firm focuses on creating long-term economic and societal value through its investments across various sectors, including healthcare and logistics.
- Total investments:
- 583
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries 8VC invests in
Stages 8VC invests in
Countries 8VC invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2.5M–$13M
- Series A
- $8M–$57M
- Series B
- $17M–$175M
Investment Focus
Industry
- Software 86 (15%)
- Health Care 59 (10%)
- Artificial Intelligence 51 (9%)
- Information Technology 43 (7%)
- Biotechnology 36 (6%)
Stage
- Series A 128 (22%)
- Seed 125 (21%)
- Series B 62 (11%)
- Series C 31 (5%)
- Funding Round 21 (4%)
Country
- United States 247 (42%)
- United Kingdom 9 (2%)
- Canada 7 (1%)
- Colombia 4 (1%)
- India 3 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alex Kolicich
Founding Partner
|
Founding Partner | Total investments: 30 | Find email | |
David Moskowitz
Principal
|
Principal | Total investments: 9 | Find email | |
Jack Moshkovich
Principal
|
Principal | Total investments: 7 | Find email | |
Sebastian Ruales
EIR
|
EIR | Total investments: 11 | Find email | |
Alex Moore
Partner
|
Partner | Total investments: 33 | Find email | |
| See all 24 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Fluxco
|
Fluxco appears to be a transformer-focused infrastructure company. | $26M / Seed / Jul 23, 2026 | |
Candid Health
|
Candid Health develops software that supports healthcare organizations in managing revenue cycle operations. Its platform automates and coordinates processes such as medical coding, claims submission, payment posting, denial management, and reimbursement workflows. The company integrates with electronic health record and practice management systemsto facilitate the exchange of clinical and billing data across healthcare providers and payers. It provides tools that enable healthcare organizations to monitor billing performance, identify claim issues, and manage revenue cycle activities through a centralized system. The company also offers analytics and workflow capabilities that support administrative and financial operations within healthcare practices. | $120M / Series D / Jul 22, 2026 | |
Sila
|
Sila Nanotechnologies is an electronics company that offers new battery materials chemistry. It works directly with leading consumer electronics and automotive OEMs to help accelerate product roadmaps, and partners with battery manufacturers commercial cell production. The company was founded in 2011 and headquartered in California, United States. | $300M / Private Equity / Jul 21, 2026 | |
Sable
|
Sable is a reliable partner that offers strict compliance, safe data processing, and no training on your data. Sable creates AI that facilitates large-scale, tailored, interactive consumer engagements. | $45M / Series A / Jul 16, 2026 | |
Default
|
The command center for modern sales teams. | $9M / Series A / Jun 16, 2026 | |
Coram AI
|
Coram AI develops a video intelligence platform to provide businesses with insights into daily operations. The company offers a novel, AI-native security platform that helps customers ranging from schools to manufacturers better monitor their sites to dramatically improve safety and efficiency. | $35M / Series B / Jun 11, 2026 | |
Minerva
|
Minerva uses advanced statistical modeling, artificial intelligence, and data science to create forecasts of income and assets. | $20M / Series A / Jun 09, 2026 | |
Generalist AI
|
Generalist AI is a robotics firm formed by a senior researcher who left Google to investigate robotics and artificial intelligence (AI) at Google Deepmind. | $400M / Series B / Jun 04, 2026 | |
morph
|
morph is a physical AI and soft robotics company that launched the shapeshifting soft robotics cells platform. | Seed / Jun 02, 2026 | |
Saris AI
|
Saris AI is an artificial intelligence company that builds agent-based workflow automation systems for financial institutions, particularly banks and credit unions. The company develops AI “agents” that handle back-office operations such as lending workflows, document processing, compliance checks, data extraction, and internal operational tasks.Its platform integrates directly with existing banking systems like core banking software and loan origination systems, allowing institutions to automate processes without replacing their current infrastructure. The system is designed to reduce manual workload by executing multi-step workflows such as data validation, case handling, and administrative processing while keeping humans in control of approvals and oversight.Saris AI focuses on improving operational efficiency by reducing processing costs and increasing output capacity through automation of repetitive and rules-based tasks. The company positions its technology as a way for financial institutions to streamline operations, improve compliance tracking, and enhance customer service responsiveness. | $28.8M / Series A / May 28, 2026 | |
| See all 583 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does 8VC invest in?
8VC invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Series A and Seed stage. Most of the 583 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is 8VC's check size?
8VC typically joins rounds of $2.5M–$13M at Seed, $8M–$57M at Series A and $17M–$175M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds 8VC participates in.
How do I contact 8VC?
Public channels for 8VC include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at 8VC?
The team at 8VC includes Alex Kolicich (Founding Partner), David Moskowitz (Principal) and Jack Moshkovich (Principal), among 24 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
